Skip to content
Ulrika Norin and Tomas Eriksson

Image -

Ulrika Norin and Tomas Eriksson

Ulrika Norin, CEO of Omnio AB, and Tomas Eriksson, the new Chairman of the board.
go to media item
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
File format:
.jpg
Size:
1920 x 1080, 172 KB
Download

Topics

Categories

Contacts

Related content

  • Ulrika Norin is the CEO of Umeå based Omnio AB and Tomas Eriksson is the new Chairman of the Board. This week Omnio gives a presentation on its treatment method at the European Wound Management Association annual meeting in Milan, Italy.

    New international board promises to take Omnio to the next level

    Umeå-based biopharmaceutical company Omnio AB, which is currently awaiting efficacy data from preclinical wound studies using recombinant plasminogen, has recently appointed an internationally experienced board of directors charged with taking the company forward.